Summit Therapeutics Inc. (SMMT) Balance Sheet
As of 2026-06-30 (10-Q), Summit Therapeutics Inc. (SMMT) reported total assets of $752.2M, total liabilities of $122.2M and shareholders' equity of $630.0M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $419.4M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
SMMTSummit Therapeutics Inc.Follow SMMT — free
—
Price chart with a free account
- Market cap
- 12.3B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
| Line | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 66.4 | 71.8 | 348.6 | 71.4 | 104.9 | 225.3 | 419.4 | |
| Short-term investments | — | — | 0.0 | 114.8 | 307.5 | 488.2 | 271.3 | |
| Receivables | 0.3 | 1.5 | 0.3 | 0.0 | — | — | — | |
| Current assets | 87.7 | 97.3 | 656.7 | 189.7 | 423.8 | 720.3 | 720.6 | |
| Total assets | 102.5 | 113.4 | 664.2 | 202.9 | 435.6 | 751.2 | 752.2 | |
| Current liabilities | 19.9 | 25.6 | 38.8 | 20.4 | 41.7 | 73.0 | 103.6 | |
| Long-term debt | — | — | 494.5 | 100.0 | 0.0 | — | — | |
| Total liabilities | 23.0 | 30.1 | 537.5 | 125.3 | 46.8 | 92.3 | 122.2 | |
| Shareholders' equity | 79.5 | 83.3 | 126.7 | 77.7 | 388.7 | 658.9 | 630.0 |
USD millions · SEC XBRL
Summit Therapeutics Inc. — questions
- How much cash does Summit Therapeutics Inc. have?
- $419.4M in cash and cash equivalents as of 2026-06-30.
- What are Summit Therapeutics Inc.'s total assets?
- $752.2M as of 2026-06-30.
- What is Summit Therapeutics Inc.'s shareholders' equity?
- $630.0M as of 2026-06-30.
Every figure on this page comes from Summit Therapeutics Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.